BioCentury
ARTICLE | Company News

Intercept gains on acquisition rumors

December 15, 2015 8:00 AM UTC

Liver disease company Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) gained $23.54 (17%) to $163.22 on Tuesday after media reports suggested multiple companies were considering bids to acquire it. Inter...